Dynamic Technology Lab Private LTD Intercept Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $496,037 - $859,455	39,588 Added 261.08%	54,751 $735,000
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $176,042 - $244,275	15,163 New	15,163 $187,000
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $229,670 - $452,652	-4,918 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$48.35 - $118.68 $237,785 - $583,668	4,918 New	4,918 $310,000
Q1 2019 May 13, 2019	SELL	$91.83 - $120.68 $216,626 - $284,684	-2,359 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $202,378 - $298,319	2,359 New	2,359 $237,000
Q3 2017 Nov 08, 2017	SELL	$57.01 - $118.75 $387,553 - $807,262	-6,798 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	6,798	6,798 $824,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.